This white paper reviews fundamental aspects of HCPs pertaining to biologic drug development and current and emerging approaches to HCP analysis. Read MoreDownload Attachment
Life Sciences Contract Research & ManufacturingCambridge, MA
BioAnalytix works with leading biotherapeutic companies in the development and application of advanced analytics and data analysis of complex biologics from candidate selection through regulatory package development. Founded in 2012 out of the Barnett Institute of Chemical and Biological Analysis in Boston, our programs are oriented around our hybrid LC-MS and data analysis platforms for precisely characterizing complex biologics. In working together with innovator partners, our team generates customized analytic data packages and works as an integrated part of the development programs to provide scientific, technical and regulatory support for advancing, de-risking and accelerating all stages of biotherapeutic development, including candidate selection/optimization and detailed characterization of biotherapeutics for IND package development, comparability assessment, control strategy design and CMC filings through licensing application.